Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174498 | SCV000225808 | benign | not specified | 2014-08-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000835734 | SCV000977541 | benign | not provided | 2018-03-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Breakthrough Genomics, |
RCV000835734 | SCV005271883 | benign | not provided | criteria provided, single submitter | not provided | ||
Bruce Budowle Laboratory, |
RCV001029394 | SCV001192180 | drug response | Tramadol response | 2018-04-28 | no assertion criteria provided | research | |
Prevention |
RCV003975274 | SCV004797799 | likely benign | ABCB1-related disorder | 2021-07-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |